By Ben Hirschler, European Pharmaceuticals Correspondent LONDON (Reuters) - GlaxoSmithKline plans to develop an experimental AIDS vaccine by "piggy-backing" on a shot against measles. Europe's biggest drug maker and France's Institut Pasteur intend to make the vaccine by fusing genes from the human....
